MAGNUM MEDICAL OÜ

11332521

General info

Name

MAGNUM MEDICAL OÜ

Registry code

11332521

VAT number

EE101106531

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

22.12.2006 (17)

Financial year

01.05-30.04

Capital

2 556.00 €

Activity

46181 - Agents specialised in the sale of other particular products 46461 - Wholesale of medicines and other pharmacy goods

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

Not submitted

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

Aktsiaselts MAGNUM

12371718

100% - 2 556.00 EUR - -

Timo Danilov

27.10.1989 (35)

- Board member -

Omanikukonto: MARGUS LINNAMÄE

05.01.1964 (60)

- - Indirect ownership

Marika Pensa

14.08.1973 (51)

- - - Board member

Veiko Vetto

13.06.1974 (50)

- - - Board member

Mari Krass

06.05.1977 (47)

- - - Chairman of the board

Financial info

2019
30.10.2020
2020
30.10.2021
2021
30.10.2022
2022
30.10.2023
Total Revenue 189 415 866 € 194 004 634 € 222 195 226 € 230 195 026 €
Net profit (loss) for the period 1 417 323 € -199 253 € 241 455 € 1 731 809 €
Profit Margin 1% -0% 0% 1%
Current Assets 58 535 279 € 60 482 708 € 68 374 726 € 75 554 638 €
Fixed Assets 15 200 536 € 18 385 724 € 28 997 000 € 44 263 000 €
Total Assets 73 735 815 € 78 868 432 € 97 371 726 € 119 817 638 €
Current Liabilities 54 663 453 € 59 995 323 € 78 257 162 € 95 971 265 €
Non Current Liabilities - - - 3 000 000 €
Total Liabilities - - - 98 971 265 €
Share Capital - - - -
Equity 19 072 362 € 18 873 109 € 19 114 564 € 20 846 373 €
Employees 23 27 26 28

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 167 415 396.2 € 5 308 432.16 € 147 525.2 € 28
2023 Q4 162 897 283.9 € 5 600 712.71 € 149 492.13 € 27
2023 Q3 157 636 240.3 € 4 920 765.65 € 141 039.4 € 27
2023 Q2 158 645 287.5 € 5 199 453.54 € 126 232.36 € 27
2023 Q1 165 923 033.8 € 4 749 714.22 € 122 333.4 € 27
2022 Q4 158 872 628.2 € 4 764 968.43 € 128 180.37 € 27
2022 Q3 137 691 725.3 € 4 269 254.6 € 112 357.1 € 26
2022 Q2 151 891 402.1 € 4 863 881.34 € 105 725.99 € 25
2022 Q1 157 351 324.8 € 4 876 949.48 € 105 486.47 € 24
2021 Q4 163 842 762.4 € 5 340 440.3 € 112 819.8 € 24
2021 Q3 148 949 831 € 4 176 436.82 € 110 710.85 € 25
2021 Q2 148 397 207.1 € 4 382 371.72 € 98 566.64 € 25
2021 Q1 139 810 514.7 € 4 392 910.02 € 91 780.5 € 27
2020 Q4 132 964 688.44 € 4 391 777.88 € 95 293.47 € 27
2020 Q3 112 719 265.12 € 4 258 339.79 € 84 986.21 € 20
2020 Q2 136 190 846.9 € 4 009 846.45 € 101 532.99 € 22
2020 Q1 122 519 768.09 € 4 631 561.38 € 89 106.31 € 24